Schnizler syndrome
- 作者: Kolkhir P.1, Muravyova E.2, Olisova O.2, Nikitin E.3, Novikov P.2, Moiseev V.4, Plieva L.5, Nekrasova T.6, Pogorelov D.7
-
隶属关系:
- Research Department of Immunodependent Dermatoses, Research Center
- Clinic of Nephrology, Visceral and Occupational Diseases
- ФБГУ Гематологический научный центр Минздрава России
- ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России
- I.M. Setchenov First Moscow State Medical University
- Hematology Research Center
- ГБОУ ВПО Ростовский государственный медицинский университет Минздрава России
- 期: 卷 17, 编号 2 (2014)
- 页面: 8-13
- 栏目: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/36834
- DOI: https://doi.org/10.17816/dv36834
- ID: 36834
如何引用文章
全文:
详细
作者简介
P. Kolkhir
Research Department of Immunodependent Dermatoses, Research Center
Email: arthate@yandex.ru
врач-аллерголог, кандидат мед. наук, старший научный сотрудник
E. Muravyova
Clinic of Nephrology, Visceral and Occupational DiseasesDepartment of Skin and Sexually-Transmitted Diseases, Therapeutic Faculty
O. Olisova
Clinic of Nephrology, Visceral and Occupational DiseasesDepartment of Skin and Sexually-Transmitted Diseases, Therapeutic Faculty
E. Nikitin
ФБГУ Гематологический научный центр Минздрава Россиикандидат мед. наук
P. Novikov
Clinic of Nephrology, Visceral and Occupational Diseasesврач, заведующий ревматологическим отделением; ревматологическое отделение
V. Moiseev
ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава РоссииDepartment of Visceral, Occupational Diseases, and Pulmonology
L. Plieva
I.M. Setchenov First Moscow State Medical Universityкандидат мед. наук, врач, заведующая вторым кожно-венерологическим отделением; клиника кожных и венерических болезней им. В.А. Рахманова
T. Nekrasova
Hematology Research Centerкандидат медицинских наук, доцент; кафедра патологической анатомии им. академика А.И. Струкова
D. Pogorelov
ГБОУ ВПО Ростовский государственный медицинский университет Минздрава Россииврач-ординатор; кафедра кожных и венерических болезней
参考
- Simon A., Asli B., Braun-Falco M., De Koning H., Feimand J.-P., Grattan C., et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy. 2013; 68(5): 562-8. doi: 10.1111/all.12129.
- Schnitzler L. Lesions urticariennes chroniques permanentes (erytheme petaloide?). Cas cliniques. J. Dermatol. Angers. 1972: abstr. 46.
- Lipsker D., Veran Y, Grunenberger F., Cribier B., Heid E., Gross-hans E. The Schnitzler syndrome: Four new cases and review of the literature. Medicine (Baltimore). 2001; 80(1): 37-44.
- Besada E., Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler’s syndrome: a case report and literature review. Clin. Rheumatol. 2010; 29(5): 567-71.
- Schuster C., Kranke B., Aberer E., Arbab E., Sturm G., Aberer W. Schnitzler syndrome: response to anakinra in two cases and a review of the literature. Int. J. Dermatol. 2009; 48(11): 1190-4.
- Volz T., Wolbing F., Fischer J., Braun M., Maggoschitz I., Schaller M., et al. Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Dermatol. Venereol. 2012; 92(4): 393-4. doi: 10.2340/00015555-1307.
- Carbone J., Paravisini A., Sarmiento E., Rodriguez-Molina J., Fernandez-Cruz E. Partial response to cyclosporine in a patient with Schnitzler’s syndrome. Allergol. Immunopathol. (Madr). 2007; 35(2): 71-3.
- Asli B., Bienvenu B., Cordoliani F., Brouet J.C., Uzunhan Y, Arnulf B., et al. Chronic urticaria and monoclonal IgM gammop-athy (Schnitzler syndrome): report of 11 cases treated with pefloxacin. Arch. Dermatol. 2007; 143(8): 1046-50.
- Murota H., Shoda Y., Ishibashi T., Sugahara H., Matsumura I., Katayama I. Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy. J. Am. Acad. Dermatol. 2009; 61 (6): 1070-5. doi: 10.1016/j.jaad.2008.12.040.
- Cascavilla N., Bisceglia M., D’Arena G. Successful treatment of Schnitzler’s syndrome with anakinra after failure of rituximab trial. Int. J. Immunopathol. Pharmacol. 2010; 23(2): 633-6.
- Eiling E., Moller M., Kreiselmaier I., Brasch J., Schwarz T. Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J. Am. Acad. Dermatol. 2007; 57(2): 361-4.
- Kyle R.A., Therneau T.M., Rajkumar S.V, Remstein E.D., Offord J.R., Larson D.R., et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003; 102(10): 3759-64.
- Launay D., Dutoit-Lefevre V, Faure E., Robineau O., Hauspie C., Sobanski V., et al. Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome. PLoS One. 2013; 8(3): e59327. doi: 10.1371/journal.pone.0059327.
- Kluger N., Bessis D., Guillot B. Tocilizumab as a potential treatment in Schnitzler syndrome. Med. Hypotheses. 2009; 72(4): 479-80. doi: 10.1016/j.mehy.2008.12.002.
- Ramadan K.M., Eswedi H.A., El-Agnaf M.R. Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab. Br. J. Dermatol. 2007; 156(5): 1072-4.
- Killock D. Lupus nephritis: A rituximab-based regimen might enable oral steroid avoidance in lupus nephritis. Nat. Rev. Rheumatol. 2013; 9(8): 443. doi: 10.1038/nrrheum.2013.102.
- Alten R., Maleitzke T. Tocilizumab: a novel humanized antiinterleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases. Ann. Med. 2013; 45(4): 357-63. doi: 10.3109/07853890.2013.771986.
- Tinazzi E., Puccetti A., Patuzzo G., Sorleto M., Barbieri A., Lunardi C. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: Report of two new cases and review of the literature. Auto-immun. Rev. 2011; 10(7): 404-9. doi: 10.1016/j.autrev.2011.01.003.
- Lipsker D., Spehner D., Drillien R., Schmitt P., Cribier B., Heid E., et al. Schnitzler syndrome: heterogeneous immuno-pathological findings involving IgM-skin interactions. Br. J. Dermatol. 2000; 142(5): 954-9.
- Asli B., Bienvenu B., Cordoliani F., Brouet J.C., Uzunhan Y., Arnulf B., et al. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin. Arch. Dermatol. 2007; 143(8): 1046-50.
- Dalhoff A., Shalit I. Immunomodulatory effects of quinolones. Lancet Infect. Dis. 2003; 3(6): 359-71.
- Sperr W.R., Natter S., Baghestanian M., Smolen J., Wolff K., Binder B.R., et al. Autoantibody reactivity in a case of Schnitler’s syndrome: evidence for a Th1-like response and detection of IgG2 antiFcsRIa antibodies. Int. Arch. Allergy Immunol. 2000; 122(2): 279-86.
- Saurat J.H., Schifferli J., Steiger G., Dayer J.M., Didierjean L. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution and receptorbinding inhibition-higher frequency in Schnitzler’s syndrome (urticaria and macroglobu-linemia). J. Allergy Clin. Immunol. 1991; 88(2): 244-56.
- Rybojad M., Moraillon I., Cordoliani F., Lebbe C., Baccard M., Fla-geul B., et al. Schnitzler syndrome and genetic deficiency of C4. Two cases report. Ann. Dermatol. Venereol. 1993; 120(11): 783-5.
- Govindaraju S., Brochot P., Ringot A.C., Paternotte L., Morrone A., Eschard J.P., Etienne J.C. Chronic urticaria-macroglobulin-emia (Schnitzler syndrome): developing to IgM myeloma. Apropos of a case. Rev. Med. Interne. 1993; 14(8): 780-3.
- Worm M., Kolde G. Schnitzler’s syndrome: successful treatment of two patients using thalidomide. Br. J. Dermatol. 2003; 148(3): 601-2.
- Lecompte M., Blais G., Bisson G., Maynard B. Schnitzler’s syndrome. Skeletal. Radiol. 1998; 27(5): 294-6.